Correction for nebie et Al., assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.
Main Authors: | Nébié, I, Edwards, N, Tiono, AB, Ewer, K, Sanou, G, Soulama, I, Sanon, S, Diarra, A, Yaro, J, Kangoye, D, Imoukhuede, E, Hill, A, Sirima, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.
by: Nébié, I, et al.
Published: (2014) -
Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP)
by: Kangoye, D, et al.
Published: (2014) -
Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
by: Morter, R, et al.
Published: (2022) -
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
by: Rampling, T, et al.
Published: (2016) -
A monovalent chimpanzee adenovirus Ebola vaccine — preliminary report
by: Rampling, T, et al.
Published: (2015)